Details for New Drug Application (NDA): 212094
✉ Email this page to a colleague
NDA 212094 describes METHADONE HYDROCHLORIDE, which is a drug marketed by Hikma, Lannett Co Inc, Specgx Llc, Vistapharm Llc, Long Grove Pharms, Mylan Institutional, Mallinckrodt Inc, Vistapharm, Ascent Pharms Inc, Aurolife Pharma Llc, Elite Labs Inc, Epic Pharma Llc, Roxane, Sun Pharm Industries, and Thepharmanetwork Llc, and is included in twenty-eight NDAs. It is available from seventeen suppliers. Additional details are available on the METHADONE HYDROCHLORIDE profile page.
The generic ingredient in METHADONE HYDROCHLORIDE is methadone hydrochloride. There are thirteen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the methadone hydrochloride profile page.
The generic ingredient in METHADONE HYDROCHLORIDE is methadone hydrochloride. There are thirteen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the methadone hydrochloride profile page.
Summary for 212094
| Tradename: | METHADONE HYDROCHLORIDE |
| Applicant: | Lannett Co Inc |
| Ingredient: | methadone hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 212094
| Mechanism of Action | Full Opioid Agonists |
Medical Subject Heading (MeSH) Categories for 212094
Suppliers and Packaging for NDA: 212094
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| METHADONE HYDROCHLORIDE | methadone hydrochloride | CONCENTRATE;ORAL | 212094 | ANDA | Lannett Company, Inc. | 0527-1926 | 0527-1926-36 | 1 BOTTLE, PLASTIC in 1 CARTON (0527-1926-36) / 30 mL in 1 BOTTLE, PLASTIC |
| METHADONE HYDROCHLORIDE | methadone hydrochloride | CONCENTRATE;ORAL | 212094 | ANDA | Lannett Company, Inc. | 0527-1926 | 0527-1926-39 | 1000 mL in 1 BOTTLE, PLASTIC (0527-1926-39) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CONCENTRATE;ORAL | Strength | 10MG/ML | ||||
| Approval Date: | Mar 3, 2021 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
